anidulafungin has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burhenne, H; Burkhardt, O; Kaever, V; Kielstein, JT | 1 |
| Ruiz Camps, I; Vázquez López, L | 1 |
| Raasch, RH | 1 |
2 review(s) available for anidulafungin and Kidney Diseases
| Article | Year |
|---|---|
[Potential of anidulafungin in hematological patients].
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Azoles; Candidiasis; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Echinocandins; Fungemia; Hematologic Diseases; Hematologic Neoplasms; Humans; Inactivation, Metabolic; Kidney Diseases; Liver Diseases; Mice; Neutropenia; Risk Factors | 2008 |
Anidulafungin: review of a new echinocandin antifungal agent.
Topics: Anidulafungin; Animals; Antifungal Agents; Biotransformation; Clinical Trials as Topic; Drug Combinations; Drug Interactions; Echinocandins; Fungi; Humans; Intestinal Absorption; Kidney Diseases; Liver Diseases; Mycoses; Peptides, Cyclic; Tissue Distribution | 2004 |
1 other study(ies) available for anidulafungin and Kidney Diseases
| Article | Year |
|---|---|
Extended daily dialysis does not affect the pharmacokinetics of anidulafungin.
Topics: Anidulafungin; Antifungal Agents; Contraindications; Echinocandins; Humans; Kidney Diseases; Mycoses; Renal Dialysis; Time Factors | 2009 |